International student visa rejections hit 20-year high
The Albanese government is facing a backlash from the higher education sector after international student visa rejections soared to a 20-year high.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
The Albanese government is facing a backlash from the higher education sector after international student visa rejections soared to a 20-year high.
The Australian Federal Government is preparing to tighten the purse strings on the National Disability Insurance Scheme.
Aussie vegetable growers demand urgent price hikes from supermarkets like Woolworths and Coles as rising fuel and fertiliser costs threaten local supply viability.
Oncolytics Biotech (NASDAQ:ONCY) has scheduled a Type C meeting with the U.S. Food and Drug Administration (FDA) for April 16, 2026, to align on a formal registrational development path for its lead immunotherapy candidate, pelareorep, in patients with advanced anal cancer.
Elbit Systems (NASDAQ:ESLT) has been awarded a contract valued at approximately $750 million (€650 million) to supply its Precise & Universal Launching System (PULS) rocket artillery to the Hellenic Armed Forces, marking a major expansion of the company’s presence in the European defense market.
AMC Entertainment (NYSE:AMC), the world's largest theatrical exhibitor, delivered a record-setting performance over the 2026 Easter holiday weekend, achieving the highest combined global admissions and concessions revenue for the holiday frame in the company’s 106-year history.
Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware and home improvement solutions, has completed the acquisition of Campbell Chain & Fittings from Apex Tool Group, a move that significantly broadens the company’s industrial Maintenance, Repair, and Operations (MRO) portfolio.
Miami International Holdings (NYSE:MIAX) reported record-breaking trading results for March 2026, as the exchange operator continues to capture a larger slice of the U.S. options and equities markets through the first quarter of the year.
IDEAYA Biosciences (NASDAQ:IDYA) announced today the first-patient-in for its Phase 1 dose-escalation clinical trial of IDE574, a potential first-in-class oral dual inhibitor of KAT6 and KAT7 targeting a broad range of solid tumors.
Former UK Chancellor Kwasi Kwarteng has endorsed Bitcoin as a potential alternative to traditional financial systems, citing concerns over fiscal instability and long-term economic sustainability.